Holen Sie sich die Stockscreener-App
149.75
0.30%
-0.45
Handel nachbörslich:
149.75
Schlusskurs vom Vortag:
$150.20
Offen:
$149.33
24-Stunden-Volumen:
222.59K
Relative Volume:
0.63
Marktkapitalisierung:
$4.33B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
50.08
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
-0.67%
1M Leistung:
+10.98%
6M Leistung:
-14.54%
1J Leistung:
-19.47%
1-Tages-Spanne:
$148.04
$150.39
1-Wochen-Bereich:
$145.47
$152.56
52-Wochen-Spanne:
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
149.75 | 4.31B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Published on: 2025-09-04 08:33:01 - Newser
Using data models to predict Krystal Biotech Inc. stock movementMarket Sentiment Summary & Consistent Growth Equity Picks - Newser
Published on: 2025-09-04 01:04:58 - Newser
Will Krystal Biotech Inc. stock recover after recent dropBear Alert & Growth Focused Investment Plans - Newser
Best data tools to analyze Krystal Biotech Inc. stockPortfolio Growth Summary & Long-Term Investment Growth Plans - Newser
What is the earnings history of Krystal Biotech Inc.Market Trend Report & AI Powered Buy/Sell Recommendations - khodrobank.com
Is Krystal Biotech Inc. a defensive stockJuly 2025 Highlights & AI Powered Buy and Sell Recommendations - khodrobank.com
Krystal Biotech (KRYS) Up 8.5% Since Last Earnings Report: Can It Continue? - ca.finance.yahoo.com
When is the best time to exit Krystal Biotech Inc.July 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser
High Growth Tech Stocks In US For September 2025 - Yahoo Finance
Applying big data sentiment scoring on Krystal Biotech IncForecast Cut & AI Forecast Swing Trade Picks - Newser
Will Krystal Biotech Inc. continue its uptrendMarket Activity Summary & Free Daily Entry Point Trade Alerts - Newser
What are Krystal Biotech Inc.’s recent SEC filings showingFed Meeting & Fast Entry and Exit Trade Plans - khodrobank.com
Analyzing recovery setups for Krystal Biotech Inc. investorsFed Meeting & Technical Confirmation Alerts - Newser
Understanding Krystal Biotech Inc.’s price movementJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
What recovery options are there for Krystal Biotech Inc.Weekly Market Outlook & Weekly Chart Analysis and Trade Guides - Newser
What candlestick patterns are forming on Krystal Biotech Inc.Trend Reversal & Capital Protection Trade Alerts - Newser
Ranking Krystal Biotech Inc. among high performing stocks via toolsRecession Risk & High Return Stock Watch Alerts - Newser
Is this a good reentry point in Krystal Biotech Inc.Weekly Market Outlook & Weekly Market Pulse Updates - Newser
Building trade automation scripts for Krystal Biotech Inc.Quarterly Portfolio Report & Real-Time Buy Zone Alerts - Newser
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025 - The Manila Times
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025: CEO to Participate in Fireside Chat and Host Investor Meetings - AInvest
Gene Therapy Leader Krystal Biotech to Present at Major Healthcare Conference in New York - Stock Titan
How to forecast Krystal Biotech Inc. trends using time seriesQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
Regression analysis insights on Krystal Biotech Inc. performancePrice Action & Daily Oversold Stock Bounce Ideas - Newser
How to use Fibonacci retracement on Krystal Biotech Inc.Trade Entry Summary & Daily Entry Point Alerts - Newser
Key metrics from Krystal Biotech Inc.’s quarterly dataWeekly Profit Report & Smart Money Movement Tracker - Newser
Published on: 2025-09-02 02:18:02 - Newser
Is Krystal Biotech Inc. in a bullish channelQuarterly Investment Review & Safe Capital Allocation Plans - khodrobank.com
Will Krystal Biotech Inc. price bounce be sustainableJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Using data filters to optimize entry into Krystal Biotech Inc.Bear Alert & Low Risk High Win Rate Stock Picks - Newser
Should I average down on Krystal Biotech Inc. stockJuly 2025 Macro Moves & Weekly Setup with ROI Potential - khodrobank.com
How do insiders feel about Krystal Biotech Inc.July 2025 Movers & Low Risk High Win Rate Stock Picks - khodrobank.com
Order flow analysis tools used on Krystal Biotech Inc.2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser
Using flow based indicators on Krystal Biotech Inc.Trade Entry Summary & Long-Term Safe Return Strategies - Newser
Relief Rally in Krystal Biotech Inc. Stock — Can It Hold getLinesFromResByArray error: size == 0 - 강소기업뉴스
Can Krystal Biotech Inc. Rally Enough to Break Even2025 Valuation Update & High Win Rate Trade Alerts - beatles.ru
Sector ETF performance correlation with Krystal Biotech Inc.Market Growth Report & Risk Managed Trade Strategies - Newser
Krystal Biotech Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Price Swings & High Conviction Buy Zone Alerts - beatles.ru
Will Krystal Biotech Inc. rebound enough to break evenRecession Risk & Weekly High Potential Stock Alerts - Newser
Is Krystal Biotech Inc. stock poised for growthMarket Performance Recap & Growth Oriented Trading Recommendations - Newser
MACD Cross Could Confirm Trend in Krystal Biotech Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Krystal Biotech Inc-Aktie (KRYS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Krishnan Suma | President, R&D |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
| Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
| Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
| Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
| Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,389 |
208,350 |
1,508,056 |
| Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,435 |
2,019,225 |
1,443,276 |
| Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
| Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
| Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
| Krishnan Krish S | President and CEO |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):